Cytokinetics Inc. buy The Goldman Sachs Group, Inc.
Start price
09.11.23
/
50%
€31.60
Target price
09.11.24
€46.68
Performance (%)
64.56%
Price
04.10.24
€52.00
Summary
This prediction is currently active. The BUY prediction by The_Goldman_Sachs_Gr for Cytokinetics Inc. has seen massive gains of 64.56%. This prediction currently runs until 09.11.24. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Cytokinetics Inc. | 10.638% | 10.638% |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $50.00 price target on the stock.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€38.80
02.03.23
02.03.23
€45.28
02.03.24
02.03.24
71.39%
03.03.24
03.03.24